Olanrewaju Ayodeji Durojaye

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 12

Top Topics

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Candida Albicans

Top Venues

The Egyptian journal of medical human genetics

Journal, genetic engineering & biotechnology

Cell & bioscience

Infection and drug resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Henrietta Onyinye Uzoeto, Judith Nnedimkpa Ajima, Amarachukwu Vivian Arazu, Glory Omini Ibiang, Samuel Cosmas, Olanrewaju Ayodeji Durojaye
Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein. Journal, genetic engineering & biotechnology 20 (1) (2022)
Glory Omini Ibiang, Joseph Malachi, Mercy Omini Ibiang, Daniel Kenechi Chukwudi, Olanrewaju Ayodeji Durojaye
Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics. The Egyptian journal of medical human genetics 23 (1) (2022)
Arome Solomon Odiba, Olanrewaju Ayodeji Durojaye, Ifeoma Maureen Ezeonu, Anthony Christian Mgbeahuruike, Bennett Chima Nwanguma
A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans . Infection and drug resistance 15 (2022)
Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Mukhtar Oluwaseun Idris, Abeeb Abiodun Yekeen, Adeola Abraham Fadahunsi, Oluwaseun Suleiman Alakanse
Identification of a Potential mRNA-based Vaccine Candidate against the SARS-CoV-2 Spike Glycoprotein: A Reverse Vaccinology Approach. ChemistrySelect 7 (7) (2022)
Olanrewaju Ayodeji Durojaye
Intracellular proteome compartmentalization: a biotin ligase-based proximity labeling approach. Cell & bioscience 11 (1) (2021)
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Victor Malachy Udowo, Abayomi Gaius Osotuyi, Glory Omini Ibiang, Miapeh Kous Gonlepa
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study. The Egyptian journal of medical human genetics 21 (1) (2020)
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Victor Malachy Udowo, Abayomi Gaius Osotuyi, Glory Omini Ibiang, Miapeh Kous Gonlepa
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study. The Egyptian journal of medical human genetics 21 (1) (2020)
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Samuel Cosmas, Glory Omini Ibiang, Mercy Omini Ibiang
An in silico epitope-based peptide vaccine design against the 2019-nCoV. The Egyptian journal of medical human genetics 21 (1) (2020)
Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Judith Nnedimkpa Ajima, Glory Omini Ibiang
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor. The Egyptian journal of medical human genetics 21 (1) (2020)
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Victor Malachy Udowo, Abayomi Gaius Osotuyi, Glory Omini Ibiang, Miapeh Kous Gonlepa
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study. The Egyptian journal of medical human genetics 21 (1) (2020)
Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Judith Nnedimkpa Ajima, Glory Omini Ibiang
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor. The Egyptian journal of medical human genetics 21 (1) (2020)
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Samuel Cosmas, Glory Omini Ibiang, Mercy Omini Ibiang
An in silico epitope-based peptide vaccine design against the 2019-nCoV. The Egyptian journal of medical human genetics 21 (1) (2020)